S&P Futures
4,163.50+10.00(+0.24%)Dow Futures
33,261.00+106.00(+0.32%)Nasdaq Futures
14,072.75+37.75(+0.27%)
AcelRx Pharmaceuticals, Inc. (ACRX)
Chart Events
Performance Outlook
| Previous Close | 1.4100 |
| Open | 1.4000 |
| Bid | 1.3000 x 900 |
| Ask | 0.0000 x 2200 |
| Day's Range | 1.3550 - 1.4200 |
| 52 Week Range | 1.0100 - 2.9400 |
| Volume | 1,533,923 |
| Avg. Volume | 1,848,031 |
| Market Cap | 165.553M |
| Beta (5Y Monthly) | 1.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4740 |
| Earnings Date | Mar 15, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.67 |
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ACRX
NEW YORK, June 20, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. (“AcelRx” or the “Company”) (NASDAQ: ACRX) and certain of its officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 21-cv-04353, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired AcelRx securities between
- GlobeNewswire
ACRX INVESTOR NEWS: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ACRX
NEW YORK, June 19, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) between March 17, 2020 and February 12, 2021, inclusive (the “Class Period”), of the important August 9, 2021 lead plaintiff deadline. SO WHAT: If you purchased AcelRx securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee
- PR Newswire
Moore Kuehn, PLLC Encourages Investors of FREQ, ACRX, or OCGN to Contact Law Firm
Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:
